Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 5
1968 8
1969 10
1970 6
1971 17
1972 11
1973 14
1974 16
1975 10
1976 24
1977 9
1978 33
1979 26
1980 15
1981 28
1982 19
1983 39
1984 29
1985 32
1986 38
1987 50
1988 59
1989 69
1990 90
1991 82
1992 88
1993 104
1994 102
1995 70
1996 96
1997 103
1998 78
1999 80
2000 91
2001 108
2002 83
2003 123
2004 99
2005 108
2006 109
2007 132
2008 121
2009 167
2010 147
2011 170
2012 164
2013 155
2014 162
2015 176
2016 176
2017 209
2018 189
2019 183
2020 185
2021 209
2022 174
2023 186
2024 60

Text availability

Article attribute

Article type

Publication date

Search Results

4,772 results

Results by year

Filters applied: . Clear all
Page 1
Acute lymphoblastic leukemia: a comprehensive review and 2017 update.
Terwilliger T, Abdul-Hay M. Terwilliger T, et al. Blood Cancer J. 2017 Jun 30;7(6):e577. doi: 10.1038/bcj.2017.53. Blood Cancer J. 2017. PMID: 28665419 Free PMC article. Review.
Acute lymphoblastic leukemia (ALL) is the second most common acute leukemia in adults, with an incidence of over 6500 cases per year in the United States alone. The hallmark of ALL is chromosomal abnormalities and genetic alterations involved in …
Acute lymphoblastic leukemia (ALL) is the second most common acute leukemia in adults, with an incidence …
Acute lymphoblastic leukaemia.
Malard F, Mohty M. Malard F, et al. Lancet. 2020 Apr 4;395(10230):1146-1162. doi: 10.1016/S0140-6736(19)33018-1. Lancet. 2020. PMID: 32247396 Review.
Acute lymphoblastic leukaemia develops in both children and adults, with a peak incidence between 1 year and 4 years. ...However, the outcome of older adults (40 years) and patients with relapsed or refractory acute lymphoblastic leukaemia remains poor …
Acute lymphoblastic leukaemia develops in both children and adults, with a peak incidence between 1 year and 4 years. ...Howev …
Biology of childhood acute lymphoblastic leukemia.
Bhojwani D, Yang JJ, Pui CH. Bhojwani D, et al. Pediatr Clin North Am. 2015 Feb;62(1):47-60. doi: 10.1016/j.pcl.2014.09.004. Pediatr Clin North Am. 2015. PMID: 25435111 Free PMC article. Review.
Giant strides have been made in the management of childhood acute lymphoblastic leukemia (ALL) over previous decades. Extensive collaborative efforts internationally have played a vital role in the remarkable progress made in not only improving therapeutic ou …
Giant strides have been made in the management of childhood acute lymphoblastic leukemia (ALL) over previous decades. E …
Recent Advances in Managing Acute Lymphoblastic Leukemia.
DeAngelo DJ, Jabbour E, Advani A. DeAngelo DJ, et al. Am Soc Clin Oncol Educ Book. 2020 May;40:330-342. doi: 10.1200/EDBK_280175. Am Soc Clin Oncol Educ Book. 2020. PMID: 32421447 Free article. Review.
Acute lymphoblastic leukemia (ALL) is characterized by chromosomal translocations and somatic mutations that lead to leukemogenesis. ...New genetic risk stratification together with the ability to measure minimal residual disease, leukemic blasts left behind …
Acute lymphoblastic leukemia (ALL) is characterized by chromosomal translocations and somatic mutations that lead to le …
How I treat relapsed acute lymphoblastic leukemia in the pediatric population.
Hunger SP, Raetz EA. Hunger SP, et al. Blood. 2020 Oct 15;136(16):1803-1812. doi: 10.1182/blood.2019004043. Blood. 2020. PMID: 32589723 Free article. Review.
Relapsed acute lymphoblastic leukemia (ALL) has remained challenging to treat in children, with survival rates lagging well behind those observed at initial diagnosis. ...Until recently, treatment options were limited to intensive cytotoxic chemotherapy with …
Relapsed acute lymphoblastic leukemia (ALL) has remained challenging to treat in children, with survival rates lagging …
How I Diagnose Acute Leukemia of Ambiguous Lineage.
Weinberg OK, Arber DA. Weinberg OK, et al. Am J Clin Pathol. 2022 Jul 1;158(1):27-34. doi: 10.1093/ajcp/aqac070. Am J Clin Pathol. 2022. PMID: 35775438 Review.
OBJECTIVES: Classification of acute leukemia involves assigning lineage by resemblance to normal progenitor cells. ...The different treatment regimens for acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) make ALA …
OBJECTIVES: Classification of acute leukemia involves assigning lineage by resemblance to normal progenitor cells. ...The diff …
MLL-Rearranged Acute Lymphoblastic Leukemia.
El Chaer F, Keng M, Ballen KK. El Chaer F, et al. Curr Hematol Malig Rep. 2020 Apr;15(2):83-89. doi: 10.1007/s11899-020-00582-5. Curr Hematol Malig Rep. 2020. PMID: 32350732 Review.
PURPOSE OF REVIEW: Rearrangements of the histone lysine [K]-MethylTransferase 2A gene (KMT2A) gene on chromosome 11q23, formerly known as the mixed-lineage leukemia (MLL) gene, are found in 10% and 5% of adult and children ALL cases, respectively. ...
PURPOSE OF REVIEW: Rearrangements of the histone lysine [K]-MethylTransferase 2A gene (KMT2A) gene on chromosome 11q23, formerly known as th …
Update on Lymphoblastic Leukemia/Lymphoma.
Luca DC. Luca DC. Clin Lab Med. 2021 Sep;41(3):405-416. doi: 10.1016/j.cll.2021.04.003. Clin Lab Med. 2021. PMID: 34304772 Review.
Lymphoblastic leukemias/lymphomas are predominantly diseases of childhood, where they represent almost all acute leukemias; however, they are also encountered with significant frequency in the adult population. ...The classification of B-lymphoblastic neoplas …
Lymphoblastic leukemias/lymphomas are predominantly diseases of childhood, where they represent almost all acute leukemias; ho …
MRD in ALL: Optimization and Innovations.
Pierce E, Mautner B, Mort J, Blewett A, Morris A, Keng M, El Chaer F. Pierce E, et al. Curr Hematol Malig Rep. 2022 Aug;17(4):69-81. doi: 10.1007/s11899-022-00664-6. Epub 2022 May 26. Curr Hematol Malig Rep. 2022. PMID: 35616771 Review.
PURPOSE OF REVIEW: Measurable residual disease (MRD) is an important monitoring parameter that can help predict survival outcomes in acute lymphoblastic leukemia (ALL). Identifying patients with MRD has the potential to decrease the risk of relapse with the i …
PURPOSE OF REVIEW: Measurable residual disease (MRD) is an important monitoring parameter that can help predict survival outcomes in acut …
Genetic Basis of Acute Lymphoblastic Leukemia.
Iacobucci I, Mullighan CG. Iacobucci I, et al. J Clin Oncol. 2017 Mar 20;35(9):975-983. doi: 10.1200/JCO.2016.70.7836. Epub 2017 Feb 13. J Clin Oncol. 2017. PMID: 28297628 Free PMC article. Review.
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, and despite cure rates exceeding 90% in children, it remains an important cause of morbidity and mortality in children and adults. The past decade has been marked by extraordinary advance …
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, and despite cure rates exceeding 90% in childre …
4,772 results